Navigation Links
Array BioPharma To Present At The Wells Fargo Securities Research And Economics 2013 Healthcare Conference
Date:6/13/2013

BOULDER, Colo., June 13, 2013 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference in Boston.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.(Logo:  http://photos.prnewswire.com/prnh/20121029/LA02195LOGO)Event:Wells Fargo Securities Research and Economics 2013 Healthcare ConferencePresenter:Ron Squarer, Chief Executive OfficerDate:Wednesday, June 19, 2013Time:9:15 a.m. Eastern Time Location:InterContinental Hotel,  Boston, MAWebcast:www.arraybiopharma.comAbout Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Array is evolving into a late-stage development company and currently expects significant progress toward generating data to support our upcoming Phase 3 / pivotal trial decisions.
Novartis expects to begin Phase 3 trials evaluating Array-invented MEK162 in NRAS-mutant melanoma and in BRAF-mutant melanoma in 2013.  In addition, Array will begin a Phase 3 trial evaluating MEK162 in low-grade serous ovarian cancer under the license agreement with Novartis in 2013.  AstraZeneca began a pivotal trial with selumetinib (an Array-invented drug) in thyroid cancer in May 2013 and expects to begin a Phase 3 trial in non-small cell lung cancer during the second half of 2013.  Three other Array-invented drugs are also approaching Phase 3 or pivotal trial decisions which are expected by the end of 2013. These include Array's wholly
'/>"/>

SOURCE Array BioPharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Array BioPharma Announces Exercise Of Underwriters Option To Purchase An Additional $17.25 Million Of 3.00% Convertible Senior Notes
2. New Date And Time For Array BioPharma Presentation At The Jefferies 2013 Global Healthcare Conference
3. Array BioPharma Announces Proposed Public Offering of Convertible Debt
4. Two Array Invented MEK Inhibitors Showcased At ASCO
5. Array BioPharma To Present At The Jefferies 2013 Global Healthcare Conference
6. Oncothyreon and Array Announce Collaboration to Develop and Commercialize anti-HER2 Compound ARRY-380
7. Array BioPharma Announces Clinical Data Presentations At The 2013 ASCO Annual Meeting
8. Array Announces Global Phase 3 Trial Evaluating MEK162 In Patients With Low-Grade Serous Ovarian Cancer
9. Array BioPharma Reports Financial Results for the Third Quarter of Fiscal 2013
10. New Versa HD System Tops Elektas Comprehensive Array of Cancer Management Solutions at 2nd ESTRO Forum
11. Array BioPharma Announces Updates on ARRY-520 Clinical Data at the 2013 International Myeloma Workshop
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Salix Pharmaceuticals, Ltd. ... International, Inc. (NYSE: VRX ) (TSX:VRX), today ... outstanding $750,000,000 aggregate principal amount of its 6.00% ... (the " Notes ") pursuant to two redemptions. ... aggregate principal amount of the Notes, and on ...
(Date:4/1/2015)... 2015  Daiichi Sankyo, Inc., the US subsidiary of ... merge with its US-based sister company, Asubio Pharmaceuticals, Inc.  ... integrated into the Daiichi Sankyo global development organization, led ... Asubio Pharmaceuticals, parent company, Asubio Pharma Co., Ltd, ... will continue to operate as a wholly owned subsidiary ...
(Date:4/1/2015)... , April 1, 2015 Valeant Pharmaceuticals International, ... today announced the expiration of the tender offer (the ... to purchase all of the outstanding shares of Salix ... price of $173.00 per share in cash, without interest, ... midnight, Eastern time, on April 1, 2015.  Valeant expects ...
Breaking Medicine Technology:Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 2Redemption of All of Salix's Outstanding 6.00% Senior Notes due 2021 3Daiichi Sankyo, Inc. and Asubio Pharmaceuticals, Inc. Merge 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 2Valeant Pharmaceuticals International, Inc. Completes Tender Offer For Salix Pharmaceuticals, Ltd. 3
(Date:4/1/2015)... Tempaper has joined forces with the Muscular Dystrophy Association ... raise critical funds to help save and improve the ... States. , Throughout the month of April, anyone who ... receive free domestic ground shipping on all orders while ... children and adults affected by muscular dystrophy and related ...
(Date:4/1/2015)... 2015 IQ Formulations , one of ... supplement companies in the U.S., today is commending GNC for ... control standards for its herbal supplements.* GNC vowed that its ... ensure the accuracy of labeling on its products. , ... IQ Formulations CEO Jay Cohen said: , “In ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 When annoying ... occur, waiting days or weeks for an appointment with ... same and next day appointments haven’t been possible within ... Forefront Dermatology’s offices have noticed demand for this level ... “We realize how important relief or answers to dermatological ...
(Date:4/1/2015)... 2015 The 2015 Deep Market ... a professional and in-depth study on the current ... with a focus on the Chinese situation. ... research are Pfizer, Lek Pharmaceuticals D.D., Dr Reddys ... Private Limited, Cadila Healthcare Limited, Sandoz Inc, Teva ...
(Date:4/1/2015)... NY (PRWEB) April 01, 2015 The ... there are “more than 123,000 patients who are waiting ... be aware of this surprising statistic. , ... Life” PSA, Erik Compton, a PGA TOUR golfer and ... and encourages Americans to become organ donors. He ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2
... the 89th General Session & Exhibition of the International ... 40th Annual Meeting of the American Association for Dental ... Association for Dental Research, lead researcher F. Cheni will ... "Biodegradable Tooth-binding Micelles Inhibit Streptococcus mutans ( ...
... -- Girls in early adolescence who form friendships with boys ... a new research. The study included 400 female and ... interviewed annually over seven years about their friendship network and ... girls tend to limit their friendships to same-sex peers. But ...
... The oldest segment of Japan,s population will likely be the ... subsequent tsunami, based on data from previous catastrophic events. Approximately ... above. "Japan,s population with the highest proportion of ... of where the world as a whole is headed," said ...
... News) -- Scientists who,ve uncovered the chemistry of mosquito sex ... such as West Nile virus and dengue fever. The ... the male sperm of Aedes aegypti mosquitoes -- ... alter female mosquitoes, tendencies to feed, produce eggs and mate. ...
... passage of the Family Smoking Prevention and Tobacco Control ... (FDA) has met the ambitious implementation deadlines set forth ... congressional briefing hosted by the American Association for Cancer ... FDA Center for Tobacco Products, reviewed the many important ...
... is delivering on its commitment to help the world,s ... an affordable, reliable, and stable treatment for malaria that ... and children in Africa. The Honourable Gary Goodyear, Minister ... Brad Trost, Member of Parliament for SaskatoonHumboldt, announced the ...
Cached Medicine News:Health News:Biodegradable tooth-binding micelles inhibit Streptococcus mutans biofilm growth 2Health News:Teen Girls Who Befriend Boys at Higher Risk for Substance Abuse 2Health News:Japanese tsunami underscores need for elder disaster preparedness 2Health News:Center director says FDA hitting milestones in tobacco law 2Health News:Government of Canada announces results in fight to save women and children with malaria 2
Autolensmeter with black/white monitor and no internal printer....
... measures all types of ... improved precision. The new ... multi-focal lenses with a ... operation easier while the ...
The Kowa Pro-lll is Kowas' flagship camera....
FF 450plus IRu Fundus camera with Visupac / System 431. Digital results in all capture modes and unlimited Visupac software....
Medicine Products: